PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-08
DOI
10.1038/s41467-021-23833-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control
- (2020) Wenjian Gan et al. NATURE CELL BIOLOGY
- A patent review of arginine methyltransferase inhibitors (2010-2018)
- (2019) Xiao Li et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2
- (2019) Joanna R. Kovalski et al. MOLECULAR CELL
- AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions
- (2019) Jianping Guo et al. NATURE CELL BIOLOGY
- Role of protein arginine methyltransferase 5 in human cancers
- (2019) Wendi Xiao et al. BIOMEDICINE & PHARMACOTHERAPY
- The regulation, functions and clinical relevance of arginine methylation
- (2019) Ernesto Guccione et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing
- (2018) Sarah V. Gerhart et al. Scientific Reports
- Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth
- (2018) Shikui Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer
- (2018) Harshita Shailesh et al. Oncotarget
- Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma
- (2017) A Gullà et al. LEUKEMIA
- Arginine Methylation: The Coming of Age
- (2017) Roméo S. Blanc et al. MOLECULAR CELL
- PRmePRed: A protein arginine methylation prediction tool
- (2017) Pawan Kumar et al. PLoS One
- Elevated expression of protein arginine methyltransferase 5 predicts the poor prognosis of breast cancer
- (2017) Ying Wu et al. TUMOR BIOLOGY
- PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression
- (2017) Kelly Chiang et al. Cell Reports
- Proteome-wide analysis of arginine monomethylation reveals widespread occurrence in human cells
- (2016) Sara C. Larsen et al. Science Signaling
- Proteome-wide analysis of arginine monomethylation reveals widespread occurrence in human cells
- (2016) Sara C. Larsen et al. Science Signaling
- The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
- (2015) Nicole Stopa et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
- (2015) GEORGE MIHAI NITULESCU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis
- (2015) Fan Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
- (2015) Elayne Chan-Penebre et al. Nature Chemical Biology
- Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666
- (2015) Kenneth W. Duncan et al. ACS Medicinal Chemistry Letters
- PTEN: Multiple Functions in Human Malignant Tumors
- (2015) Michele Milella et al. Frontiers in Oncology
- Posttranslational regulation of Akt in human cancer
- (2014) Chia-Hsin Chan et al. Cell and Bioscience
- The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
- (2014) Amancio Carnero et al. Frontiers in Oncology
- Ins and Outs of Kinase DFG Motifs
- (2013) Daniel K. Treiber et al. CHEMISTRY & BIOLOGY
- The role of arginine methylation in the DNA damage response
- (2013) Yannick Auclair et al. DNA REPAIR
- Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis
- (2013) Pengda Liu et al. NATURE CELL BIOLOGY
- PRMT5 dimethylates R30 of the p65 subunit to activate NF- B
- (2013) H. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PI3K-PKB/Akt Pathway
- (2012) B. A. Hemmings et al. Cold Spring Harbor Perspectives in Biology
- Akt signalling in health and disease
- (2011) Ingeborg Hers et al. CELLULAR SIGNALLING
- Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation
- (2011) Jung-Mao Hsu et al. NATURE CELL BIOLOGY
- PRMT5 regulates Golgi apparatus structure through methylation of the golgin GM130
- (2010) Zhongwei Zhou et al. CELL RESEARCH
- Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models
- (2010) Carmen Blanco-Aparicio et al. PLoS One
- Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition
- (2010) Wen-I Wu et al. PLoS One
- Protein Arginine Methylation in Mammals: Who, What, and Why
- (2009) Mark T. Bedford et al. MOLECULAR CELL
- The nuts and bolts of AGC protein kinases
- (2009) Laura R. Pearce et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Synthesis and structure based optimization of novel Akt inhibitors
- (2008) Blaise Lippa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2
- (2008) J. Huang et al. MOLECULAR AND CELLULAR BIOLOGY
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started